Company file
keyboard_backspaceBack to directoryIdentity
TreeFrog Therapeutics
TreeFrog Therapeutics is a startup company aiming at providing access to cell therapies for millions of patients. TreeFrog Therapeutics has developed C-Stem, a high-throughput cell encapsulation technology allowing the mass-production and differentiation of stem cells in industrial bioreactors.This proprietary technology platform provides an end-to-end and scalable solution that dramatically improves the quality of therapeutic cells and reduce treatment costs. Since its incorporation in November 2018 in Bordeaux, France, TreeFrog Therapeutics has experienced strong acceleration, raising over €13M ($14,65M) in 2019. In January 2020, TreeFrog Therapeutics joined the FrenchTech120, an elite programme for the fastest-growing technology companies in France. The team – currently 28 staff - moved into a brand new production facility of 13,000 sq ft in June 2020.
TreeFrog Therapeutics is partnering with pharmaceutical companies for the co-development of novel cell therapies based on pluripotent stem cells.
Contact
30 avenue Gustave Eiffel, Bâtiment A
33600 Pessac
France
Activities
- Manufacturer
- CMC
- CMC
- Bioproduction
- Bioproduction
- Scale-Up
- Automate manufacturing
- Automated high-throughput microbioreactor system
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Non-GMP pilot batch
- GMP batch
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Cell acquisition
- Autologus
- Allogenic
- Cell Bank
- Tissue acquisition
- Off the shelf
- Apheresis
- Target cell isolation
- iPS reprogrammation
- Differentiated Cell
- Production Cell
- Safety donor-derived therapies
- Cell Expansion
- Bioreacteur
- Wave
- Cell factory
- Other
- Conditionning
- Conditionning
